Company

Profluent Bio Inc.

Profluent Bio uses artificial intelligence to design functional proteins.

About

Profluent Bio develops proteins for human health and industrial applications using generative machine learning models. Founded in 2022, the company is based in Emeryville, US. It raised USD 106 million in Series B funding co-led by Altimeter Capital and Bezos Expeditions in November 2025.

3Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in